Risks of Nonkeratinocyte Skin Cancers Higher in Solid Organ Transplant Recipients
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
A population-based study characterized risks of nonkeratinocyte skin cancers in immunosuppressed solid organ transplant recipients.
The incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
The burden from melanoma is estimated to increase to 510,000 new cases and 96,000 deaths by 2040.
Data suggest the overall incidence of melanoma in the United States is stabilizing after nearly a century of continuous increase.
At the start of the pandemic, there was an immediate 34.3% decline in the estimated mean cancer incidence volume.
Fixed-dose combination treatment with relatlimab plus nivolumab improved progression-free survival when compared with nivolumab alone.
Opdualag is a fixed-dose combination of nivolumab and relatlimab.
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.
Prior studies have linked the gut microbiome with outcomes of anti-PD-1 therapy, but findings have been inconsistent.
FDA-approved drug therapies for cutaneous melanoma.